Skip to content
Raxibacumab
N/A (raxibacumab) is an antibody pharmaceutical. Raxibacumab was first approved as N/a on 2012-12-14.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
N/a
Drug Products
FDA
EMA
Reference product - 351(a)
Reference product - 351(a)
Interchangeable product - 351(k)
Interchangeable product - 351(k)
Biosimilar product - 351(k)
Biosimilar product - 351(k)
Raxibacumab
Tradename
Proper name
Company
Number
Date
Products
N/AraxibacumabEmergent Manufacturing Operations BaltimoreN-125349 RX2012-12-14
1 products
Labels
FDA
EMA
Brand Name
Status
Last Update
raxibacumabBiologic Licensing Application2021-06-14
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
Expiration
Code
raxibacumab, N/A, Emergent Manufacturing Operations Baltimore LLC
2119-12-14Orphan excl.
Patent Expiration
No data
ATC Codes
J: Antiinfectives for systemic use
J06: Immune sera and immunoglobulins
J06B: Immunoglobulins
J06BC: Antibacterial monoclonal antibodies
J06BC02: Raxibacumab
HCPCS
No data
Clinical
Clinical Trials
147 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
HypertensionD006973EFO_0000537I10261119341
Healthy volunteers/patients171220
Type 2 diabetes mellitusD003924EFO_0001360E1123319
Chronic renal insufficiencyD051436N1812227
Diabetic nephropathiesD003928EFO_00004012147
Heart failureD006333EFO_0003144I5012115
Metabolic syndromeD024821EFO_0000195E88.811315
Coronary artery diseaseD003324I25.144
Cardiovascular diseasesD002318EFO_0000319I982114
ProteinuriaD011507HP_0000093R80134
Show 19 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Atrial fibrillationD001281EFO_0000275I48.01213
Glucose intoleranceD018149HP_0000833R73.0333
Systemic lupus erythematosusD008180EFO_0002690M32212
ObesityD009765EFO_0001073E66.9112
Type 1 diabetes mellitusD003922EFO_0001359E10112
Myocardial ischemiaD017202EFO_1001375I20-I25112
Liver cirrhosisD008103EFO_0001422K74.011
Inferior wall myocardial infarctionD056989EFO_100098311
Kidney transplantationD01603011
Oxidative stressD018384EFO_100190511
Show 11 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
HypercholesterolemiaD006937HP_000312422
NeoplasmsD009369C8011
Covid-19D000086382U07.111
GlioblastomaD005909EFO_000051511
Cognitive dysfunctionD060825G31.8411
VasculitisD014657EFO_0006803M3111
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Therapeutic equivalencyD01381022
Stable anginaD060050I20.811
Diabetes mellitusD003920EFO_0000400E08-E1311
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
OligospermiaD009845N46.111
TeratozoospermiaD00007266011
AsthenozoospermiaD05362711
Male infertilityD007248EFO_0004248N4611
Morbid obesityD009767EFO_000107411
AgingD000375GO_0007568R41.8111
Hereditary nephritisD009394EFO_0004128Q87.8111
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameRAXIBACUMAB
INNraxibacumab
Description
Raxibacumab (human mab)
Classification
Antibody
Drug classmonoclonal antibodies
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
Identifiers
PDB
CAS-ID565451-13-0
RxCUI
ChEMBL IDCHEMBL2108638
ChEBI ID
PubChem CID
DrugBankDB08902
UNII ID794PGL549S (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 366 documents
View more details
Safety
Black-box Warning
Black-box warning for: Raxibacumab
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
32,670 adverse events reported
View more details